Author

Carsten Brunn

Observed name: C Brunn

Institution: Cartesian Therapeutics, Inc. (United States)

Observed institutions: University of Washington, Selecta Biosciences (United States), Cartesian Therapeutics, Inc. (United States), Freie Universität Berlin

ORCID: 0000-0002-4151-2198

Observed ORCID: 0000-0002-4151-2198

OpenAlex ID: A5047425591

Cytokines as Vaccine Adjuvants

1995 · Penny Dong, Carsten Brunn, et al. · Pharmaceutical biotechnology · 29

BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trial

2026 · Renee R. Fedak, Rachel N. Ruggerie, et al. · Nature Medicine · 24

ImmTORTM to amplify the efficacy and reduce immunogenicity of biologics

2021 · Carsten Brunn, Takashi Kei Kishimoto · Emerging Topics in Life Sciences · 2

The gamma/delta T cell receptor (TCR) is expressed on less than 50% of intraepithelial lymphocytes (IEL) in human intestine

1990 · R Ullrich, H Schieferdecker, et al. · Springer eBooks

Works count: 4

Citation count: 55

H-index: 2

I10-index: 2